Hepatitis B virus (HBV) is a prototype for liver-specific pathogens in which the failure of the immune system to mount an effective response leads to chronic infection. Our understanding of the immune response to HBV is incomplete, largely due to the narrow host restriction of this pathogen and the limitations of existing experimental models. We have developed a murine model for studying human HBV replication, immunogenicity, and control. After transfection of hepatocytes in vivo with a replicationcompetent, over-length, linear HBV genome, viral antigens and replicative intermediates were synthesized and virus was secreted into the blood. Viral antigens disappeared from the blood as early as 7 days after transfection, coincident with the appearance of antiviral antibodies. HBV transcripts and replicative intermediates disappeared from the liver by day 15, after the appearance of antiviral CD8 ؉ T cells. In contrast, the virus persisted for at least 81 days after transfection of NOD͞Scid mice, which lack functional T cells, B cells, and natural killer (NK) cells. Thus, the outcome of hydrodynamic transfection of HBV depends on the host immune response, as it is during a natural infection. The methods we describe will allow the examination of viral dynamics in a tightly controlled in vivo system, the application of mutagenesis methods to the study of the HBV life cycle in vivo, and the dissection of the immune response to HBV using genetically modified mice whose immunoregulatory and immune effector functions have been deleted or overexpressed. In addition, this methodology represents a prototype for the study of other known and to-be-discovered liver-specific pathogens.H epatitis B virus (HBV) is a human hepadnavirus that causes acute and chronic hepatitis and hepatocellular carcinoma (1). Although an effective vaccine has been available for two decades, an estimated 350 million people worldwide are chronically infected. A significant proportion of chronic infections terminate in hepatocellular carcinoma, leading to more than one million deaths annually (2).A reproducible tissue culture model of HBV infection does not exist, nor is HBV infectious for immunologically well-defined laboratory animals. Much of our current understanding of the viral life cycle after HBV infection is derived from studies of duck HBV (DHBV) (3) and woodchuck HBV (WHV) (4) infection in their natural hosts, HBV-infected chimpanzees (5-7), and HBV transgenic mice (8-10). For various reasons, however, none of these models is ideal. DHBV (11) and WHV (12, 13) are genetically divergent from HBV, and immunological studies in genetically outbred and immunologically uncharacterized ducks and woodchucks are difficult. Chimpanzee experiments are limited by cost, availability, and ethical considerations, whereas transgenic mice are immunologically tolerant to the virus, thereby compromising the greatest potential strength of a mouse model of HBV infection. We present here work describing a recently developed mouse model that alleviates many of thes...